Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.

Iñigo Rúa-FigueroaFrancisco J López-LongoVíctor Del CampoMaría Galindo-IzquierdoEsther UriarteJulián Torre-CisnerosPaloma VelaEva TomeroFrancisco Javier NarváezAlejandro OlivéMercedes FreireEva SalgadoJosé Luis AndreuVíctor Martínez-TaboadaJaime Calvo-AlénBlanca Hernández-CruzEnrique RayaVíctor QuevedoLorena Expósito PérezAntonio Fernández-NebroMónica IbañezÈlia Pascual-VallsDavid Rúa-FigueroaAntonio NaranjoJosé M Pego-Reigosa

Published in: The Journal of rheumatology (2019)

Bacteremia occurred mostly in patients with active SLE and was frequently associated with severe flares and corticosteroid use. Recurrence and mortality were high. Immunosuppressors, comorbidities, and disease-related damage were associated with bacteremia.

Keyphrases

risk factors
end stage renal disease
gram negative
ejection fraction
systemic lupus erythematosus
newly diagnosed
chronic kidney disease
oxidative stress
early onset
cardiovascular events
patient reported outcomes
adipose tissue
metabolic syndrome
drug induced
skeletal muscle
insulin resistance